Security key
03771D102
Apimeds Pharmaceuticals US, Inc. - Common Stock (APUS)
CUSIP: 03771D102
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 395,700
- Total 13F value
- $648,947
- Share change
- -4,283
- SEC-reported price per share
- $1.64
- Number of holders
- 7
- Value change
- -$15,296
- Number of buys
- 6
- Number of sells
- 4
- Shares outstanding
- 12,584,892
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
7
Top holders
7
APUS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Apimeds Pharmaceuticals US, Inc. SEC filings
Apimeds Pharmaceuticals US, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03771D102
Recent filing periods:
Ownership snapshot
Top reported holders of APUS - Apimeds Pharmaceuticals US, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ayrton Capital LLC
Disclosed value leader
Inscobee Inc.
Comparable rows
10/15
Latest evidence
31 Dec 2025
13D/G
3/4/5
13F
Lead comparable stake: 10%
5 rows are not safely comparable across share classes.
13D/G row: Ayrton Capital LLC
Showing 1-6 of 15 holder rows.
Quick read
Ayrton Capital LLC leads the comparable SEC ownership view at 10%.
10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ayrton Capital LLC's linked filing trail.
Comparable ownership
Top 5
Ayrton Capital LLC
10%
Inscobee Inc.
34%
Hemenway Trust Co LLC
2%
VANGUARD GROUP INC
0.47%
GEODE CAPITAL MANAGEMENT, LLC
0.24%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ayrton Capital LLC |
13D/G
|
10%
|
$2,612,429
1,397,021 shares
|
$0 | 31 Dec 2025 |
| Inscobee Inc. |
3/4/5
10%+ Owner
|
34%
|
$8,805,900
4,316,618 shares
|
— | 12 May 2025 |
| Hemenway Trust Co LLC |
13F
Company
|
2%
|
$445,000
250,000 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.47%
|
$105,005
58,992 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.24%
|
$54,741
30,754 shares
|
— | 30 Sep 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.22%
|
$49,650
27,893 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
395,700
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
8
Q4 2025 holders
7
Holder diff
-1
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend